Biopharma’s ongoing quest to develop COVID-19 drugs and vaccines, plus growing industry demand for producing various types of new therapies, are fueling the $1.5-billion expansion of manufacturing ...
Officials at Cytiva report that the company has completed significant expansion projects in several locations in the U.S., Europe, and Asia as part of its ongoing commitment to customers developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results